ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager 6 February 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video) 26 January 2026
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
Sintana Energy Strengthens Position with ExxonMobil Settlement, Eyes Growth in 2026 – Auctus Advisors LLP 4 February 2026
Naked Wines Broker Tips Over 120% Price Upside on Profitable Growth – Panmure Liberum 2 February 2026
Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus 28 January 2026
ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager 6 February 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating a Challenging Residential Market with Strategic Insights 9 February 2026
Standard Chartered PLC (STAN.L) Stock Analysis: Evaluating Growth Amidst Volatility and a 9.72% ROE 9 February 2026
Unilever PLC (ULVR.L) Stock Analysis: Navigating the Consumer Goods Giant’s Market Position and Analyst Ratings 9 February 2026
Weir Group PLC (WEIR.L): Analyst Ratings Highlight Strong Buy Consensus Amidst Impressive Stock Performance 9 February 2026
Reckitt Benckiser Group PLC (RKT.L) Stock Analysis: Navigating a 6.29% Upside Amid Strong ROE 9 February 2026
ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager 6 February 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video) 26 January 2026
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
Sintana Energy Strengthens Position with ExxonMobil Settlement, Eyes Growth in 2026 – Auctus Advisors LLP 4 February 2026
Naked Wines Broker Tips Over 120% Price Upside on Profitable Growth – Panmure Liberum 2 February 2026
Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus 28 January 2026
ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager 6 February 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating a Challenging Residential Market with Strategic Insights 9 February 2026
Standard Chartered PLC (STAN.L) Stock Analysis: Evaluating Growth Amidst Volatility and a 9.72% ROE 9 February 2026
Unilever PLC (ULVR.L) Stock Analysis: Navigating the Consumer Goods Giant’s Market Position and Analyst Ratings 9 February 2026
Weir Group PLC (WEIR.L): Analyst Ratings Highlight Strong Buy Consensus Amidst Impressive Stock Performance 9 February 2026
Reckitt Benckiser Group PLC (RKT.L) Stock Analysis: Navigating a 6.29% Upside Amid Strong ROE 9 February 2026
Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook on a Biotech with a 10.5% Upside Potential 3 February 2026
Mirum Pharmaceuticals, Inc. (MIRM): A Promising Biotech Play with a 12.88% Upside Potential 27 January 2026
Mirum Pharmaceuticals, Inc. (MIRM) Investor Outlook: Robust Buy Ratings Signal Potential Upside 20 January 2026
Mirum Pharmaceuticals, Inc. (MIRM) Investor Outlook: Promising Upside with 47.2% Revenue Growth 13 January 2026
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A 36.45% Potential Upside Captivates Investors 6 January 2026
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Force with 28.54% Potential Upside 30 December 2025
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Investors Eye a 27% Upside Potential in Biotech Innovation 23 December 2025
Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook Reveals a 52.89% Potential Upside 16 December 2025
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Exploring a 32.83% Potential Upside for Investors 9 December 2025
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Strong Buy Ratings Signal Potential 25.69% Upside 2 December 2025
Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook Shows Promising 21.88% Upside in Biotechnology Sector 25 November 2025
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Unveiling a 23.5% Upside Potential with Strong Buy Ratings 11 November 2025
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Navigating a 17.92% Potential Upside in the Biotech Sector 4 November 2025
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Exploring a 16.72% Potential Upside with Robust Revenue Growth 28 October 2025
Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook on a Biotech with 14.4% Upside Potential 21 October 2025
Mirum Pharmaceuticals (MIRM) Stock Analysis: Robust Revenue Growth and Strong Buy Ratings Capture Investor Attention 14 October 2025
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Exploring a 11.68% Potential Upside Amid Robust Revenue Growth 7 October 2025
Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook Highlights Robust Revenue Growth and Analyst Confidence 30 September 2025
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Look at Growth Opportunities with a Promising 7.67% Upside 23 September 2025
Mirum Pharmaceuticals (MIRM) Stock Analysis: Evaluating the Growth Potential in Rare Disease Therapeutics 9 September 2025
Time Finance Profit Margin Rises as Lending Hits Record £235M in Interim Results (Video) 2 February 2026
Oriole Resources: Strong Grades and Growing Confidence at MB01 North in Cameroon (Video) 27 January 2026
The Diverse Income Trust: Why Gervais Williams Is Doubling Down on Overlooked UK Small Caps (video) 27 January 2026
Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video) 26 January 2026
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
RECI presentation: High-yielding, controlled-risk lending supports near 10% dividend yield 4 December 2025
CMC Markets Presentation: API-Driven Growth Surges as Westpac Deal Ignites Strategic Shift 2 December 2025
ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager 6 February 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Sintana Energy Strengthens Position with ExxonMobil Settlement, Eyes Growth in 2026 – Auctus Advisors LLP 4 February 2026
Naked Wines Broker Tips Over 120% Price Upside on Profitable Growth – Panmure Liberum 2 February 2026
Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus 28 January 2026
ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager 6 February 2026
Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed 4 February 2026
Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager 4 February 2026
Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video) 26 January 2026
Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video) 23 January 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating a Challenging Residential Market with Strategic Insights 9 February 2026
Standard Chartered PLC (STAN.L) Stock Analysis: Evaluating Growth Amidst Volatility and a 9.72% ROE 9 February 2026
Unilever PLC (ULVR.L) Stock Analysis: Navigating the Consumer Goods Giant’s Market Position and Analyst Ratings 9 February 2026
Weir Group PLC (WEIR.L): Analyst Ratings Highlight Strong Buy Consensus Amidst Impressive Stock Performance 9 February 2026
Reckitt Benckiser Group PLC (RKT.L) Stock Analysis: Navigating a 6.29% Upside Amid Strong ROE 9 February 2026
